Boostrix is indicated for booster vaccination against diphtheria, tetanus and pertussis of individuals from the age of four years onwards (see Dosage & Administration).
Boostrix is also indicated for passive protection against pertussis in early infancy following maternal immunisation during pregnancy (see Dosage & Administration, Use in Pregnancy & Lactation and Pharmacology: Pharmacodynamics under Actions).
The administration of Boostrix should be based on official recommendations.